150 related articles for article (PubMed ID: 19202567)
1. Epithelioid osteosarcoma of the jaw.
Cozza R; Devito R; De Ioris MA; Zama M; Boldrini R; Fidani P; Donfrancesco A
Pediatr Blood Cancer; 2009 Jul; 52(7):877-9. PubMed ID: 19202567
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
[TBL] [Abstract][Full Text] [Related]
3. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
Meyers PA; Schwartz CL; Krailo MD; Healey JH; Bernstein ML; Betcher D; Ferguson WS; Gebhardt MC; Goorin AM; Harris M; Kleinerman E; Link MP; Nadel H; Nieder M; Siegal GP; Weiner MA; Wells RJ; Womer RB; Grier HE;
J Clin Oncol; 2008 Feb; 26(4):633-8. PubMed ID: 18235123
[TBL] [Abstract][Full Text] [Related]
4. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.
Meyers PA; Schwartz CL; Krailo M; Kleinerman ES; Betcher D; Bernstein ML; Conrad E; Ferguson W; Gebhardt M; Goorin AM; Harris MB; Healey J; Huvos A; Link M; Montebello J; Nadel H; Nieder M; Sato J; Siegal G; Weiner M; Wells R; Wold L; Womer R; Grier H
J Clin Oncol; 2005 Mar; 23(9):2004-11. PubMed ID: 15774791
[TBL] [Abstract][Full Text] [Related]
5. Metastatic osteosarcoma.
Daw NC; Billups CA; Rodriguez-Galindo C; McCarville MB; Rao BN; Cain AM; Jenkins JJ; Neel MD; Meyer WH
Cancer; 2006 Jan; 106(2):403-12. PubMed ID: 16353204
[TBL] [Abstract][Full Text] [Related]
6. Extraskeletal osteosarcoma of the breast in an adolescent girl.
Zils K; Ebner F; Ott M; Müller J; Baumhoer D; Greulich M; Rehnitz D; Rempen A; Schaetzle S; Wilhelm M; Bielack S
J Pediatr Hematol Oncol; 2012 Aug; 34(6):e261-3. PubMed ID: 22246152
[TBL] [Abstract][Full Text] [Related]
7. SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients.
Le Deley MC; Guinebretière JM; Gentet JC; Pacquement H; Pichon F; Marec-Bérard P; Entz-Werlé N; Schmitt C; Brugières L; Vanel D; Dupoüy N; Tabone MD; Kalifa C;
Eur J Cancer; 2007 Mar; 43(4):752-61. PubMed ID: 17267204
[TBL] [Abstract][Full Text] [Related]
8. Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials.
Eselgrim M; Grunert H; Kühne T; Zoubek A; Kevric M; Bürger H; Jürgens H; Mayer-Steinacker R; Gosheger G; Bielack SS
Pediatr Blood Cancer; 2006 Jul; 47(1):42-50. PubMed ID: 16206218
[TBL] [Abstract][Full Text] [Related]
9. Progression of osteosarcoma after high-dose methotrexate: over-rescue by folinic acid.
Cohen IJ
Pediatr Hematol Oncol; 2003 Dec; 20(8):579-81. PubMed ID: 14578026
[TBL] [Abstract][Full Text] [Related]
10. Osteosarcoma: the same old drugs or more?
Bielack SS; Marina N; Ferrari S; Helman LJ; Smeland S; Whelan JS; Reaman GH
J Clin Oncol; 2008 Jun; 26(18):3102-3; author reply 3104-5. PubMed ID: 18565904
[No Abstract] [Full Text] [Related]
11. Multimodality treatment of osteosarcoma: radiation in a high-risk cohort.
Mahajan A; Woo SY; Kornguth DG; Hughes D; Huh W; Chang EL; Herzog CE; Pelloski CE; Anderson P
Pediatr Blood Cancer; 2008 May; 50(5):976-82. PubMed ID: 18213710
[TBL] [Abstract][Full Text] [Related]
12. Interdisciplinary combined treatment of craniofacial osteosarcoma with neoadjuvant and adjuvant chemotherapy and excision of the tumour: a retrospective study.
Thiele OC; Freier K; Bacon C; Egerer G; Hofele CM
Br J Oral Maxillofac Surg; 2008 Oct; 46(7):533-6. PubMed ID: 18436357
[TBL] [Abstract][Full Text] [Related]
13. Epithelioid osteosarcoma presenting as a rapidly expanding maxillary mass.
Rinaggio J; Kewitt GF; McGuff HS
Head Neck; 2007 Jul; 29(7):705-9. PubMed ID: 17230564
[TBL] [Abstract][Full Text] [Related]
14. [Value of ifosfamide in neoadjuvant therapy for osteosarcoma].
Orthopade; 2013 Dec; 42(12):1072. PubMed ID: 24482827
[No Abstract] [Full Text] [Related]
15. Ifosfamide in the neoadjuvant treatment of osteogenic sarcoma.
Maki RG
J Clin Oncol; 2012 Jun; 30(17):2033-5. PubMed ID: 22565001
[No Abstract] [Full Text] [Related]
16. Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcoma.
Lashkari A; Chow WA; Valdes F; Leong L; Phan V; Twardowski P; Kapoor N; Molina A; Al-Kadhimi Z; Frankel P; Somlo G
Anticancer Res; 2009 Aug; 29(8):3281-8. PubMed ID: 19661346
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival in osteosarcoma patients following retinoblastoma using doxorubicin, cisplatin, and methotrexate.
Stine KC; Saylors RL; Saccente S; Becton DL
Med Pediatr Oncol; 2003 Jul; 41(1):77-8. PubMed ID: 12764753
[No Abstract] [Full Text] [Related]
18. Osteogenic sarcoma of the jaw: a 10-year experience.
Fernandes R; Nikitakis NG; Pazoki A; Ord RA
J Oral Maxillofac Surg; 2007 Jul; 65(7):1286-91. PubMed ID: 17577490
[TBL] [Abstract][Full Text] [Related]
19. Epithelioid trophoblastic tumour: report of a case in the fallopian tube.
Parker A; Lee V; Dalrymple C; Valmadre S; Russell P
Pathology; 2003 Apr; 35(2):136-40. PubMed ID: 12745461
[TBL] [Abstract][Full Text] [Related]
20. Intraarterial Cisplatin and intravenous adriamycin in nonmetastatic osteosarcoma of the extremities: a single institution experience in Taiwan.
Chiu TJ; Wang JW; Chen YJ; Tang Y; Huang CH
Chang Gung Med J; 2009; 32(1):72-80. PubMed ID: 19292942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
